--- title: Newsroom | COVID-19 description: COVID-19 | --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities) December 4, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/groundbreaking-myalgic-encephalomyelitis-study-identifies-over-250-core-genes-shared-biology-with-long-covid-and-dozens-of-drug-repurposing-opportunities#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 4, 2025, 9:09:27 AM - [Tweet](https://twitter.com/share) Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-share-first-insights-with-me/cfs-long-covid-participants-in-metx-research-study) September 18, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-share-first-insights-with-me/cfs-long-covid-participants-in-metx-research-study) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-share-first-insights-with-me/cfs-long-covid-participants-in-metx-research-study#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 18, 2024, 3:00:00 PM - [Tweet](https://twitter.com/share) Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [PrecisionLife and Metrodora Institute launch clinical trials to accelerate the diagnosis and treatment of ME/CFS and Long Covid patients](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-launch-clinical-trials-to-accelerate-the-diagnosis-and-treatment-of-me/cfs-and-long-covid-patients) May 14, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-launch-clinical-trials-to-accelerate-the-diagnosis-and-treatment-of-me/cfs-and-long-covid-patients) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-and-metrodora-institute-launch-clinical-trials-to-accelerate-the-diagnosis-and-treatment-of-me/cfs-and-long-covid-patients#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 14, 2024, 11:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [PrecisionLife project awarded Innovate UK Grant to improve diagnosis and treatment of ME/CFS and Long Covid](https://news.lifesciencenewswire.com/newsroom/precisionlife-project-awarded-innovate-uk-grant-to-improve-diagnosis-and-treatment-of-me/cfs-and-long-covid) December 15, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-project-awarded-innovate-uk-grant-to-improve-diagnosis-and-treatment-of-me/cfs-and-long-covid) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-project-awarded-innovate-uk-grant-to-improve-diagnosis-and-treatment-of-me/cfs-and-long-covid#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 15, 2023, 8:00:00 AM - [Tweet](https://twitter.com/share) Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US](https://news.lifesciencenewswire.com/newsroom/nih-and-exothera-collaborate-to-produce-gmp-intranasal-vaccine-against-sars-cov-2-for-clinical-phase-i/ii-trial-in-africa-and-us) August 16, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/nih-and-exothera-collaborate-to-produce-gmp-intranasal-vaccine-against-sars-cov-2-for-clinical-phase-i/ii-trial-in-africa-and-us) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/nih-and-exothera-collaborate-to-produce-gmp-intranasal-vaccine-against-sars-cov-2-for-clinical-phase-i/ii-trial-in-africa-and-us#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 16, 2023, 9:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) July 18, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 18, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections](https://news.lifesciencenewswire.com/newsroom/takara-bio-announces-partnership-for-the-distribution-of-ce-ivd-solutions-for-respiratory-tract-infections) September 6, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/takara-bio-announces-partnership-for-the-distribution-of-ce-ivd-solutions-for-respiratory-tract-infections) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/takara-bio-announces-partnership-for-the-distribution-of-ce-ivd-solutions-for-respiratory-tract-infections#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 6, 2022, 10:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) #### [ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions announce a new antibody cocktail effective against major variants of SARS-CoV-2](https://news.lifesciencenewswire.com/newsroom/proteogenix-aseem-healthcare-and-trident-biopharm-solutions-announce-a-new-antibody-cocktail-effective-against-major-variants-of-sars-cov-2) June 7, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/proteogenix-aseem-healthcare-and-trident-biopharm-solutions-announce-a-new-antibody-cocktail-effective-against-major-variants-of-sars-cov-2) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/proteogenix-aseem-healthcare-and-trident-biopharm-solutions-announce-a-new-antibody-cocktail-effective-against-major-variants-of-sars-cov-2#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 7, 2022, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) #### [DOLPHIN Vagus Stimulation receives Health Canada Approval for covid-19 (ARDS)](https://news.lifesciencenewswire.com/newsroom/dolphin-vagus-stimulation-receives-health-canada-approval-for-covid-19-ards) February 9, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/dolphin-vagus-stimulation-receives-health-canada-approval-for-covid-19-ards) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/dolphin-vagus-stimulation-receives-health-canada-approval-for-covid-19-ards#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 9, 2022, 1:30:00 PM - [Tweet](https://twitter.com/share) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/covid-19/page/2) ##### Browse more news ## Recent releases #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) #### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) October 1, 2026 The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)